MedTrace Logo

Clinical Evaluation of Cordio App in Adult ADHF Patients

NCT03266029 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2021-03-05

No results posted yet for this study

Summary

Observational study on ADHF patients at one site in Israel. After signing informed consent and undergoing screening assessments, eligible patients will record sentences into a smartphone. The app will upload the vocal data to the sponsor's servers for analysis. The patient will record at hospital: admittion, release. Before hospital release, if applicable and upon patient agrreement, an app will be installed in a smartphone in order to continue the recording at home.

Conditions

  • Congestive Heart Failure

Interventions

DEVICE

Cordio App

Sponsors & Collaborators

  • Cordio Medical

    lead INDUSTRY

Principal Investigators

  • Zaher Azzam, Prof. · Rambam Health Care Facility

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-24
Primary Completion
2020-08-31
Completion
2020-12-10

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03266029 on ClinicalTrials.gov